DUBLIN–(BUSINESS WIRE)–The “Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.
This report provides an in-depth analysis of the global nonalcoholic steatohepatitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
By 2050, this is projected at >29 million people – a 165% increase over the 2000 level. It is to be noted that these projections imply a steady increase in the overall prevalence of diabetes, from 3.99% in 2000 to 7.21% in 2050.
However, diagnosis of the nonalcoholic steatohepatitis can be difficult to capture in an early stage and can take years before patients show any sort of symptoms which is a major factor hampering the nonalcoholic steatohepatitis treatment market.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nonalcoholic steatohepatitis treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global nonalcoholic steatohepatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nonalcoholic steatohepatitis treatment market
Company Profiles:
- AstraZeneca Plc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Conatus Pharmaceuticals
- Enzo Biochem, Inc.
- GENFIT SA
- Galmed Pharmaceuticals Ltd.
- Gilead Science
- Immuron Ltd.
- Intercepts Pharmaceuticals
- Novo Nordisk
- Raptor Pharmaceutical Corporation
- Tobira Therapeutics, Inc.
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Publisher Opportunity Map
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- Pipeline Product Analysis
- Epidemiology Study
Global Nonalcoholic Steatohepatitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Detailed Segmentation:
Global Nonalcoholic Steatohepatitis Treatment Market, By Drug:
- Cenicriviroc
- Elafibranor
- Ocaliva (Obeticholic Acid)
- Selonsertib
Global Nonalcoholic Steatohepatitis Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Nonalcoholic Steatohepatitis Treatment Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
For more information about this report visit https://www.researchandmarkets.com/r/t0uc4y
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
